Ingrid L. Scully

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Uğur Şahin, Alexander Muik, Evelyna Derhovanessian et al. · Nature · 2020 · 2K citations · Full text

Vaccinology, Vaccination, Vaccine Development +7

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Annette B. Vogel, Isis Kanevsky, Ye Che et al. · Nature · 2021 · 725 citations · Full text

Vaccination, Bnt162b Vaccines, Vaccine Development +4

Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age

Donald Hurley, Carl Griffin, Mariano Young et al. · Clinical Infectious Diseases · 2020 · 156 citations · Full text

Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years

Brandon Essink, Charu Sabharwal, Kevin Cannon et al. · Clinical Infectious Diseases · 2021 · 154 citations · Full text

A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates

Annette B. Vogel, Isis Kanevsky, Ye Che et al. · 2020 · 138 citations · Full text

Vaccination, Vaccine Development, Prevents Lung Infection +15